UBS upgraded its stance on Next on Friday to ‘buy’ from ‘neutral’ and lifted the price target to 11,700p from 10,500p.
Fusion Antibodies announced on Friday that its OptiMAL validation project with the US National Cancer Institute (NCI) was ...
Reabold Resources announced on Friday that it has completed the acquisition of additional shares in Rathlin Energy UK from ...
Asian markets mostly advanced on Friday, following gains in US equities as investors assessed Big Tech earnings.
Prospex Energy reported a significant increase in production and revenue from the Selva Malvezzi production concession in ...
Texas-based energy giant Chevron reported fourth-quarter earnings of $3.2bn on Friday, an increase from $2.3bn a year earlier ...
Cohort announced the completed acquisition of EM Solutions on Friday, following earlier announcements in November and January ...
Pharma giant Novartis comfortably beat market forecasts with its fourth-quarter results on Friday, with the Swiss firm ...
US futures pointed to a firmer open on Wall Street on Friday as investors eyed the latest inflation reading. At 1120 GMT, Dow ...
Analysts at Berenberg lowered their target price on Endeavour Mining from 2,400.0p to 2,300.0p on Friday but said yields ...
Celadon Pharmaceuticals reported on Friday that it has received £0.897m of a £1m drawdown request from its committed credit ...
Faron Pharmaceuticals announced on Friday that it has identified the final patient for its BEXMAB phase two dose optimisation ...